Form 8-K - Current report:
SEC Accession No. 0001558370-19-011695
Filing Date
2019-12-30
Accepted
2019-12-30 08:15:19
Documents
31
Period of Report
2019-12-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 40736
2 EX-99.1 ex-99d1.htm EX-99.1 49370
3 EX-99.2 ex-99d2.htm EX-99.2 68269
4 GRAPHIC ex-99d1g001.jpg GRAPHIC 2875
5 GRAPHIC ex-99d2g001.gif GRAPHIC 70016
6 GRAPHIC ex-99d2g002.gif GRAPHIC 52548
7 GRAPHIC ex-99d2g003.gif GRAPHIC 176367
8 GRAPHIC ex-99d2g004.gif GRAPHIC 80119
9 GRAPHIC ex-99d2g005.gif GRAPHIC 78958
10 GRAPHIC ex-99d2g006.gif GRAPHIC 83135
11 GRAPHIC ex-99d2g007.gif GRAPHIC 80079
12 GRAPHIC ex-99d2g008.gif GRAPHIC 87803
13 GRAPHIC ex-99d2g009.gif GRAPHIC 91198
14 GRAPHIC ex-99d2g010.gif GRAPHIC 67121
15 GRAPHIC ex-99d2g011.gif GRAPHIC 62088
16 GRAPHIC ex-99d2g012.gif GRAPHIC 64661
17 GRAPHIC ex-99d2g013.gif GRAPHIC 43735
18 GRAPHIC ex-99d2g014.gif GRAPHIC 45957
19 GRAPHIC ex-99d2g015.gif GRAPHIC 51502
20 GRAPHIC ex-99d2g016.gif GRAPHIC 66274
21 GRAPHIC ex-99d2g017.gif GRAPHIC 64581
22 GRAPHIC ex-99d2g018.gif GRAPHIC 65049
23 GRAPHIC ex-99d2g019.gif GRAPHIC 51377
24 GRAPHIC ex-99d2g020.gif GRAPHIC 49685
25 GRAPHIC ex-99d2g021.gif GRAPHIC 46880
26 GRAPHIC ex-99d2g022.gif GRAPHIC 49361
27 GRAPHIC ex-99d2g023.gif GRAPHIC 74086
28 GRAPHIC ex-99d2g024.gif GRAPHIC 104712
29 GRAPHIC ex-99d2g025.gif GRAPHIC 73179
30 GRAPHIC ex-99d2g026.gif GRAPHIC 70184
31 GRAPHIC ex-99d2g027.gif GRAPHIC 59999
  Complete submission text file 0001558370-19-011695.txt   2795098
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 191314823
SIC: 2834 Pharmaceutical Preparations